Physician profile
Samir P Patel
NPI 1992965982
$6,823.24
in general payments reported to CMS, 2019-2025
20 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.38 · 2020: $178 · 2021: $3,868 · 2022: $833 · 2023: $1,190 · 2024: $425 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,541 · Travel and Lodging: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,541.40 |
| Travel and Lodging | $351.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,031.38 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $1,729.83 | 2020-2025 | Proclaim |
| Si-Bone, INC. | $1,157.24 | 2021-2022 | |
| Nevro Corp. | $488.52 | 2019-2024 | Senza |
| United Imaging Healthcare North America LLC | $419.58 | 2023 | |
| Medtronic, INC. | $292.33 | 2021 | |
| Pacira Therapeutics, INC. | $135.06 | 2021 | |
| Globus Medical, INC. | $129.90 | 2025 | Senza |
| Forte Bio-Pharma LLC | $84.22 | 2021 | |
| Arbor Pharmaceuticals, INC. | $71.30 | 2021 | |
| Scilex Pharmaceuticals INC. | $49.50 | 2021-2022 | |
| Amgen INC. | $47.73 | 2021-2022 | |
| Horizon Therapeutics Plc | $43.08 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $33.91 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.70 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.82 | 2021 | |
| Relievant Medsystems, INC. | $21.18 | 2022 | |
| Ibsa Pharma INC. | $13.48 | 2021 | |
| Biodelivery Sciences International, INC. | $11.91 | 2021 | |
| Redhill Biopharma INC. | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.